JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for SUPERNUS PHARMACEUTICALS INC · Experience in developing and commercializing products that treat central nervous system

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $20,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

issues related to the pharmaceutical industry

Medicare/Medicaid

issues related to Medicare drug reimbursement

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.